Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
- PMID: 34452529
- PMCID: PMC8402645
- DOI: 10.3390/v13081665
Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
Abstract
An escalating pandemic of the novel SARS-CoV-2 virus is impacting global health, and effective antivirals are needed. Umifenovir (Arbidol) is an indole-derivative molecule, licensed in Russia and China for prophylaxis and treatment of influenza and other respiratory viral infections. It has been shown that umifenovir has broad spectrum activity against different viruses. We evaluated the sensitivity of different coronaviruses, including the novel SARS-CoV-2 virus, to umifenovir using in vitro assays. Using a plaque assay, we revealed an antiviral effect of umifenovir against seasonal HCoV-229E and HCoV-OC43 coronaviruses in Vero E6 cells, with estimated 50% effective concentrations (EC50) of 10.0 ± 0.5 µM and 9.0 ± 0.4 µM, respectively. Umifenovir at 90 µM significantly suppressed plaque formation in CMK-AH-1 cells infected with SARS-CoV. Umifenovir also inhibited the replication of SARS-CoV-2 virus, with EC50 values ranging from 15.37 ± 3.6 to 28.0 ± 1.0 µM. In addition, 21-36 µM of umifenovir significantly suppressed SARS-CoV-2 virus titers (≥2 log TCID50/mL) in the first 24 h after infection. Repurposing of antiviral drugs is very helpful in fighting COVID-19. A safe, pan-antiviral drug such as umifenovir could be extremely beneficial in combating the early stages of a viral pandemic.
Keywords: SARS-CoV; SARS-CoV-2; antiviral activity; coronaviruses; umifenovir.
Conflict of interest statement
The authors declare no financial or commercial conflicts of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8402645/bin/viruses-13-01665-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8402645/bin/viruses-13-01665-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8402645/bin/viruses-13-01665-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8402645/bin/viruses-13-01665-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8402645/bin/viruses-13-01665-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8402645/bin/viruses-13-01665-g006.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8402645/bin/viruses-13-01665-g007.gif)
Similar articles
-
Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro.Viruses. 2021 Apr 9;13(4):650. doi: 10.3390/v13040650. Viruses. 2021. PMID: 33918914 Free PMC article.
-
Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.Antiviral Res. 2021 Sep;193:105127. doi: 10.1016/j.antiviral.2021.105127. Epub 2021 Jul 1. Antiviral Res. 2021. PMID: 34217752 Free PMC article.
-
In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.Virol J. 2020 Sep 9;17(1):136. doi: 10.1186/s12985-020-01401-2. Virol J. 2020. PMID: 32907596 Free PMC article.
-
Antiviral strategies against human coronaviruses.Infect Disord Drug Targets. 2007 Mar;7(1):59-66. doi: 10.2174/187152607780090757. Infect Disord Drug Targets. 2007. PMID: 17346212 Review.
-
[Umifenovir and coronavirus infections: a review of research results and clinical practice].Ter Arkh. 2020 Dec 26;92(11):91-97. doi: 10.26442/00403660.2020.11.000713. Ter Arkh. 2020. PMID: 33720612 Review. Russian.
Cited by
-
In Vitro Antiviral Activity of a New Indol-3-carboxylic Acid Derivative Against SARS-CoV-2.Acta Naturae. 2023 Oct-Dec;15(4):83-91. doi: 10.32607/actanaturae.26623. Acta Naturae. 2023. PMID: 38234608 Free PMC article.
-
Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses.Biomolecules. 2023 Sep 26;13(10):1452. doi: 10.3390/biom13101452. Biomolecules. 2023. PMID: 37892134 Free PMC article. Review.
-
Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2.Molecules. 2023 Sep 13;28(18):6603. doi: 10.3390/molecules28186603. Molecules. 2023. PMID: 37764378 Free PMC article. Review.
-
Conformational Screening of Arbidol Solvates: Investigation via 2D NOESY.Pharmaceutics. 2023 Jan 9;15(1):226. doi: 10.3390/pharmaceutics15010226. Pharmaceutics. 2023. PMID: 36678855 Free PMC article.
-
Antiviral Potential of Plants against COVID-19 during Outbreaks-An Update.Int J Mol Sci. 2022 Nov 5;23(21):13564. doi: 10.3390/ijms232113564. Int J Mol Sci. 2022. PMID: 36362351 Free PMC article. Review.
References
-
- Hendley J.O., Fishburne H.B., Gwaltney J.M., Jr. Coronavirus infections in working adults. Eight-year study with 229 E and OC 43. Am. Rev. Respir. Dis. 1972;105:805–811. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous